Top list · Worldwide
59 RNA therapeutics startups worldwide have raised money in rounds we track. These are the 50 that have raised the most, $3.7B between them, with the United States the most common home.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Founded 2015Cambridge, United Kingdom$317Mlast round Apr 2026ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
Founded 2021Cambridge, United States$300Mlast round May 2023Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Founded 2022New York, United States$270Mlast round Apr 2023Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Founded 2017Cambridge, United States$267Mlast round Mar 2026A biotechnology company developing RNA technologies to shape the future of gene therapy
Founded 2018Seattle, United States$260Mlast round Jul 2026Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Founded 2014Bedford, United States$255Mlast round Mar 2024Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
Founded 2019Cambridge, United States$221Mlast round Aug 2022Nutcracker Therapeutics is a biotechnology company based in Emeryville, California, specializing in mRNA therapeutics and a unique GMP manufacturing platform.
Founded 2018Emeryville, United States$167Mlast round Mar 2022AIRNA is a biotechnology company founded in 2021, focused on discovering and developing RNA editing therapeutics.
Founded 2021Cambridge, United States$155Mlast round Apr 2025Skyhawk Therapeutics is a clinical-stage biotechnology company located in Waltham, Massachusetts.
Founded 2016Waltham, United States$133Mlast round Sept 2021Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.
Founded -South San Francisco, United States$100Mlast round Dec 2025DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.
Founded 2017San Diego$100Mlast round Mar 2021Atalanta Therapeutics is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for central nervous system (CNS) diseases.
Founded 2018Boston, United States$97Mlast round Jan 2025Changing lives is what drives us at ProQR Therapeutics.
Founded 2012Leiden, Netherlands$68Mlast round Jun 2026Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.
Founded -Woburn, United States$64Mlast round May 2026Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.
Founded 2016Watertown, United States$61Mlast round Jul 2023Switch Therapeutics is a preclinical-stage biotechnology company founded in 2020, focused on developing innovative RNA interference (RNAi) therapies for central
Founded 2020San Francisco, United States$52Mlast round Mar 2023Arnatar Therapeutics is a biotechnology company founded in 2022, based in San Diego, California, with operations in Shanghai, China.
Founded 2022San Diego, United States$52Mlast round Apr 2024Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Founded 2001United States$49Mlast round Jun 2004Aerska is a biotechnology company focused on developing targeted RNA medicines to treat brain diseases.
Founded -Dublin, Ireland$49Mlast round May 2026Aptadir Therapeutics is a biotechnology startup based in Milan, focused on developing RNA inhibitor-based therapies for cancer and genetic disorders.
Founded -Milano, United Kingdom$47Mlast round Sept 2026NextRNA Therapeutics is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies that target long non-coding RNAs (lncRNAs).
Founded 2020Boston, United States$47Mlast round Mar 2022Starna Therapeutics is a biotechnology company based in Suzhou, China, founded in August 2021.
Founded 2021Suzhou, China$42Mlast round Oct 2025Argo Biopharma is a clinical-stage biotechnology company based in Shanghai, China, founded in 2021.
Founded 2021Shanghai, China$41Mlast round Nov 2023ARTHEx Biotech is a clinical-stage biotechnology company based in Paterna, Valencia, Spain.
Founded 2019Paterna, Spain$41Mlast round Sept 2025SRTD Biotech GmbH is a biotechnology company based in Jülich, Germany, specializing in the development of RNA-based therapeutics.
Founded -Juelich, Germany$35Mlast round Nov 2026Avidity is a RNA therapeutics software solutions provider company.
Founded 1996Aurora, United States$32Mlast round Oct 2018Ractigen Therapeutics is a clinical-stage biopharmaceutical company based in Suzhou, Jiangsu, China, founded in 2016.
Founded 2017Suzhou, China$30Mlast round Jan 2022CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Founded 2016Cambridge, United States$30Mlast round Dec 2025OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Founded 2018Waltham, United States$30Mlast round Mar 2022Envisagenics is an AI-driven biotechnology company founded in 2014, focusing on the discovery and development of novel RNA splicing therapeutics for oncology an
Founded 2014New York, United States$27Mlast round Jun 2024TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Founded 2016Newton, United States$26Mlast round Apr 2026Rona Therapeutics is a biotechnology company based in Shanghai, China, founded in 2021.
Founded 2021Shanghai, China$25Mlast round Mar 2025Eleven Therapeutics is a biotechnology company founded in 2020, specializing in next-generation RNA therapeutics.
Founded 2020Cambridge, United Kingdom$22Mlast round Aug 2022Tacit Therapeutics created RNA-targeting treatments for devastating diseases.
Founded 2021South San Francisco, United States$19Mlast round Mar 2026Innovac Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.
Founded -Cambridge, United States$18Mlast round Sept 2023Oligon Therapeutics Inc.
Founded -Montreal, United States$14Mlast round Sept 2025Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.
Founded -China$14Mlast round May 2023Vico Therapeutics is a clinical-stage genetic medicines company based in Leiden, the Netherlands.
Founded 2019Leiden, Netherlands$12Mlast round Jun 2024Therna Biosciences is a biotechnology company based in San Francisco, founded in 2023.
Founded 2025San Francisco, United States$10Mlast round Aug 2025Amaroq Therapeutics is a biotechnology company based in New Zealand that focuses on developing innovative cancer therapeutics targeting long non-coding RNAs (lncRNAs).
Founded 2021Auckland, New Zealand$9.7Mlast round Jul 2021Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.
Founded -Cambridge, United States$9.0Mlast round Feb 2025Heqet Therapeutics is a pre-clinical stage biotechnology company based in Turin, Italy.
Founded -Deerfield, United Kingdom$8.8Mlast round Mar 2022Expansion Therapeutics is a biotechnology company based in Boston, focused on developing oral medicines for severe RNA-mediated diseases, particularly neurodege
Founded 2016Jupiter, United States$6.9Mlast round Jan 2023Crucible Therapeutics is a biotechnology company based in Sheffield, England, founded in 2023.
Founded 2023United Kingdom$6.3Mlast round Mar 2025pHion Therapeutics is a biopharmaceutical company based in Belfast, Northern Ireland, focused on developing therapeutic and prophylactic mRNA vaccines.
Founded 2017Belfast, United Kingdom$6.2Mlast round Jun 2023HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.
Founded 2018Seattle, United States$6.2Mlast round Sept 2026XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.
Founded -Kyoto, Japan$6.1Mlast round Jan 2025CamGene Therapeutics is a biotechnology company based in Cambridge, UK, focused on developing RNA-based gene medicines specifically for hearing loss.
Founded 2024Cambridge, United Kingdom$5.4Mlast round May 2026ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Founded 2021Brisbane, United States$4.6Mlast round Apr 2026Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back rNA therapeutics startups worldwide in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
O
A
XAI startups worldwide10,238 companies · $830B
GV
V
RPBiotech startups worldwide7,127 companies · $70B
D
B
FTBig data startups worldwide3,812 companies · $220BAF
R
SFintech startups worldwide3,200 companies · $94B
O
A
BAI startups that raised in 20262,922 companies · $540B in 2026
FT
CE
PEnergy providers startups worldwide2,808 companies · $152B
P
OMarketing tech startups worldwide2,728 companies · $28B